Tenet Healthcare Corporation (THC)
NYSE: THC · IEX Real-Time Price · USD
135.22
+2.05 (1.54%)
At close: May 31, 2024, 4:00 PM
135.28
+0.06 (0.04%)
After-hours: May 31, 2024, 7:47 PM EDT
Tenet Healthcare Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Tenet Healthcare stock have an average target of 117.89, with a low estimate of 81 and a high estimate of 153. The average target predicts a decrease of -12.82% from the current stock price of 135.22.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for THC stock from 18 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 8 | 8 | 9 |
| Buy | 6 | 6 | 6 | 8 | 8 | 8 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 17 | 17 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $107 → $140 | Buy | Maintains | $107 → $140 | +3.53% | May 30, 2024 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $126 → $150 | Strong Buy | Maintains | $126 → $150 | +10.93% | May 30, 2024 |
| Baird | Baird | Buy Initiates $153 | Buy | Initiates | $153 | +13.15% | May 30, 2024 |
| Barclays | Barclays | Buy Maintains $113 → $147 | Buy | Maintains | $113 → $147 | +8.71% | May 2, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $109 → $136 | Buy | Maintains | $109 → $136 | +0.58% | May 1, 2024 |
Financial Forecast
Revenue This Year
20.63B
from 20.56B
Increased by 0.31%
Revenue Next Year
21.47B
from 20.63B
Increased by 4.08%
EPS This Year
8.99
from 5.71
Increased by 57.37%
EPS Next Year
9.41
from 8.99
Increased by 4.75%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 22.5B | 23.3B | 24.6B | 24.5B | 25.5B |
| Avg | 20.6B | 21.5B | 22.5B | 23.5B | 24.5B |
| Low | 19.8B | 20.6B | 21.4B | 22.8B | 23.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.6% | 13.0% | 14.4% | 8.6% | 8.2% |
| Avg | 0.3% | 4.1% | 4.9% | 4.5% | 4.0% |
| Low | -3.8% | -0.4% | -0.5% | 1.4% | 0.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.57 | 12.32 | 13.48 | 12.37 | 13.00 |
| Avg | 8.99 | 9.41 | 10.56 | 11.90 | 12.50 |
| Low | 8.07 | 7.95 | 8.82 | 11.54 | 12.13 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 85.1% | 37.1% | 43.2% | 17.1% | 9.3% |
| Avg | 57.4% | 4.8% | 12.2% | 12.7% | 5.1% |
| Low | 41.3% | -11.6% | -6.3% | 9.3% | 2.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.